Skip to main content
. Author manuscript; available in PMC: 2014 Jul 29.
Published in final edited form as: J Pharmacol Exp Ther. 2005 Dec 21;317(1):317–325. doi: 10.1124/jpet.105.097758

TABLE 1.

Sequences of mutagenesis oligonucleotides

Oligos Sequences (5′ to 3′)
IR1-sensea,b GTCTTGGGCTGCCCTTAGACGCGTGAATTCTTAGGCAAATAGATAAT
IR1-antisense ATTATCTATTTGCCTAAGAATTCACGCGTCTAAGGGCAGCCCAAGAC
R331L-sense TGCGGTTGAAGCTATGTTCCTTCTTTCAGCTGAGATTTTCAATAAGAAAC
R331L-antisense GTTTCTTATTGAAAATCTCAGCTGAAAGAAGGAACATAGCTTCAACCGCA
L340Y-sense CAGCTGAGATTTTCAATAAGAAATATCCGTCTGGGCATTCTGACCTATTGG
L340Y-antisense CCAATAGGTCAGAATGCCCAGACGGATATTTCTTATTGAAAATCTCAGCTG
R351L-sense GGGCATTCTGACCTATTGGAAGAACTAATTCGAAATAGTGGTATCTCTGAT
R351L-antisense ATCAGAGATACCACTATTTCGAATTAGTTCTTCCAATAGGTCAGAATGCCC
I352Y-sense CATTCTGACCTATTGGAAGAAAGATATCGAAATAGTGGTATCTCTGATGA
I352Y-antisense TCATCAGAGATACCACTATTTCGATATCTTTCTTCCAATAGGTCAGAATG
a

The IR1 element in the BSEP promoter is underlined.

b

The mutated nucleotides are in bold.

HHS Vulnerability Disclosure